Envision Healthcare (EVHC) Given a $41.00 Price Target by Jefferies Group Analysts

Jefferies Group set a $41.00 price target on Envision Healthcare (NYSE:EVHC) in a research report report published on Tuesday morning. The firm currently has a buy rating on the stock.

Several other equities research analysts also recently issued reports on EVHC. Bank of America lowered their price target on Envision Healthcare from $72.00 to $60.00 and set a buy rating on the stock in a research report on Monday, October 9th. SunTrust Banks set a $55.00 price target on Envision Healthcare and gave the company a buy rating in a research report on Sunday, October 15th. Robert W. Baird reaffirmed a buy rating and issued a $70.00 price target on shares of Envision Healthcare in a research report on Tuesday, October 17th. Cantor Fitzgerald downgraded Envision Healthcare from an overweight rating to a neutral rating and set a $30.00 price target on the stock. in a research report on Wednesday, November 1st. Finally, KeyCorp set a $67.00 target price on Envision Healthcare and gave the stock a buy rating in a research report on Wednesday, November 1st. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of Buy and a consensus price target of $44.19.

Envision Healthcare (EVHC) traded down $0.72 during midday trading on Tuesday, reaching $33.14. The company’s stock had a trading volume of 2,485,700 shares, compared to its average volume of 2,284,869. Envision Healthcare has a one year low of $23.77 and a one year high of $73.00. The company has a current ratio of 3.01, a quick ratio of 3.00 and a debt-to-equity ratio of 0.89. The company has a market capitalization of $4,093.31, a price-to-earnings ratio of 10.45, a P/E/G ratio of 0.88 and a beta of 0.57.

Envision Healthcare (NYSE:EVHC) last posted its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.08). The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $2.03 billion. Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. Envision Healthcare’s quarterly revenue was up 142.0% on a year-over-year basis. During the same quarter last year, the business earned $1.13 earnings per share. analysts forecast that Envision Healthcare will post 2.56 earnings per share for the current fiscal year.

Envision Healthcare declared that its board has authorized a stock repurchase program on Monday, September 18th that authorizes the company to repurchase $250.00 million in shares. This repurchase authorization authorizes the company to buy up to 4.5% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in EVHC. Commonwealth Bank of Australia lifted its position in Envision Healthcare by 24.3% during the 2nd quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after buying an additional 410 shares in the last quarter. LMR Partners LLP bought a new stake in Envision Healthcare during the 2nd quarter worth about $205,000. Palisade Capital Management LLC NJ bought a new stake in shares of Envision Healthcare in the 3rd quarter valued at about $229,000. Cutter & CO Brokerage Inc. raised its holdings in shares of Envision Healthcare by 11.1% in the 2nd quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock valued at $230,000 after purchasing an additional 367 shares during the period. Finally, Flinton Capital Management LLC raised its holdings in shares of Envision Healthcare by 18.7% in the 2nd quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock valued at $280,000 after purchasing an additional 704 shares during the period.

WARNING: “Envision Healthcare (EVHC) Given a $41.00 Price Target by Jefferies Group Analysts” was published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://sportsperspectives.com/2017/12/20/envision-healthcare-evhc-given-a-41-00-price-target-by-jefferies-group-analysts.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply